May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Progression of Visual Loss in Untreated AMD Eyes With Subfoveal Exudation Depends on Initial Visual Acuity
Author Affiliations & Notes
  • L.V. Del Priore
    Ophthalmology, Columbia, New York, NY
  • A.R. Shah
    Ophthalmology, Columbia, New York, NY
  • Footnotes
    Commercial Relationships  L.V. Del Priore, None; A.R. Shah, None.
  • Footnotes
    Support  Robert L. Burch III Fund
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 2189. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      L.V. Del Priore, A.R. Shah; Progression of Visual Loss in Untreated AMD Eyes With Subfoveal Exudation Depends on Initial Visual Acuity . Invest. Ophthalmol. Vis. Sci. 2006;47(13):2189.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Previous clinical trials in exudative AMD demonstrate large differences in the behavior of untreated control eyes. For example, there was a large range of initial visual acuity scores in control eyes in the Macular Photocoagulation Study (45 letters), Treatment of Age–Related Macular Degeneration with Photodynamic Therapy Study (TAP, 52.6 letters), Macugen (52.6 letters), Subfoveal Surgery Trial (35 letters) and Anecortave Acetate (47 letters) study; final visual acuity score after two years also varied widely in untreated eyes in these studies. Herein we test the hypothesis that the behavior of the control eyes is essentially the same across all studies, with the apparent differences arising from different entry times for each study.

Methods: : The visual acuity score of control eyes from the above studies was plotted on a double reciprocal plot [1/LETTERS LOST versus 1/MONTHS AFTER ENROLLMENT]. Individual data sets were translated along the horizontal axis to correct for differences in time of entry into a clinical trial.

Results: : After horizontal translations the pooled data from the control eyes in these studies fits a straight line when 1/LETTERS LOST is plotted versus 1/MONTHS (r2 = 0.952). The line intercept predicts that an untreated eye will eventually lose 75 letters (final visual acuity score = 10 letters = 20/640); the slope of the line predicts that without treatment ½ of the visual acuity score is lost within 10.8 months after the onset of exudation.

Conclusions: : The rate of visual loss of subfoveal exudative AMD is linear on a double reciprocal plot with a high correlation coefficient (0.952) if adjustments are made for initial visual acuity at the time of entry into study. Our results suggest that the major variables influencing the final visual acuity score are the initial visual acuity score and the timing of treatment.

Keywords: age-related macular degeneration • clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials • macula/fovea 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.